Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Orchid Pharma Ltd

NSE: ORCHPHARMA · BSE: 524372 · Pharmaceuticals & Biotechnology · 15 announcements

Share price: ₹1,064.90
Market cap: ₹6,377 Cr
Revenue (annual): ₹811.3 Cr
Net profit (annual): ₹20.55 Cr
P/E (TTM): 735.8×Sector 50.4×
Promoter holding: 69.84%+0.00% QoQ
FII holding: 0.80%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 6 Financial Results 3 Management Change 1 Capital Structure Change 1 Board Meeting Outcome 1 Annual Report 1 Annual General Meeting 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

14 Aug 2026 18:44 IST NSE

Financial Results

Orchid Pharma Q4 FY26 Results: Net Profit ₹25.8 Cr, Down 24.1% YoY

Orchid Pharma Ltd reported revenue from operations of ₹368.3 Cr (+3.0% YoY) and net profit of ₹25.8 Cr (-24.1% YoY) for Q4 FY26.

Key figure: Net profit ₹25.8 Cr · -24.1% YoY

Open full results → Read the filing ↗

14 Aug 2026 18:34 IST BSE

Financial Results

Orchid Pharma Q1 FY27 Results: Turns Profitable, Net Profit ₹3.2 Cr

Orchid Pharma Ltd reported revenue from operations of ₹304.2 Cr (+15.6% YoY) and net profit of ₹3.2 Cr for Q1 FY27.

Key figure: Net profit ₹3.2 Cr

Open full results → Read the filing ↗

25 May 2026 19:34 IST NSE

Financial ResultsAlfa Alert

Orchid Pharma Q4 FY26 Results: Net Profit ₹23.8 Cr, Up 6.7% YoY

Orchid Pharma Ltd reported revenue from operations of ₹237.6 Cr (+0.0% YoY) and net profit of ₹23.8 Cr (+6.7% YoY) for Q4 FY26.

Key figure: Net profit ₹23.8 Cr · +6.7% YoY

Open full results → Read the filing ↗